Aliases & Classifications for Mucositis

MalaCards integrated aliases for Mucositis:

Name: Mucositis 12 55 44 15
Inflammatory Disease of Mucous Membrane 73
Gastrointestinal Mucositis 73

Classifications:



External Ids:

Disease Ontology 12 DOID:0080178
MeSH 44 D052016

Summaries for Mucositis

Disease Ontology : 12 A gastrointestinal system disease that is characterized by painful inflammation and ulceration of the mucous membranes lining the digestive tract.

MalaCards based summary : Mucositis, also known as inflammatory disease of mucous membrane, is related to kaposi sarcoma and diphtheria, and has symptoms including oral manifestations, signs and symptoms, digestive and catarrh. An important gene associated with Mucositis is CSF2 (Colony Stimulating Factor 2), and among its related pathways/superpathways are ERK Signaling and TGF-Beta Pathway. The drugs Miconazole and Nystatin have been mentioned in the context of this disorder. Affiliated tissues include colon, t cells and bone, and related phenotypes are growth/size/body region and behavior/neurological

Wikipedia : 76 Mucositis is the painful inflammation and ulceration of the mucous membranes lining the digestive tract,... more...

Related Diseases for Mucositis

Diseases related to Mucositis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 681)
# Related Disease Score Top Affiliating Genes
1 kaposi sarcoma 30.3 CSF2 MTOR VEGFA
2 diphtheria 30.0 CSF2 EGF IL2
3 lymphoma, non-hodgkin, familial 29.3 ABCB1 CSF2 CSF3 IL2
4 acute leukemia 29.3 ABCB1 CSF3 MTHFR
5 pyogenic granuloma 29.1 MTOR VEGFA
6 acute lymphocytic leukemia 28.3 CSF2 CSF3 IL2 MTHFR TYMS
7 malaria 28.2 CSF2 CSF3 IL2 TYMS VEGFA
8 myeloma, multiple 28.0 ABCB1 CSF2 CSF3 IL2 MTOR VEGFA
9 stomatitis 27.3 CSF2 CSF3 DPYD FGF7 MTOR TYMS
10 colorectal cancer 25.1 ABCB1 DPYD EGF IL2 MTHFR MTOR
11 venous malformations, multiple cutaneous and mucosal 12.4
12 mucosal melanoma 12.3
13 multiple mucosal neuroma 12.1
14 multiple endocrine neoplasia, type iib 11.8
15 white sponge nevus 1 11.7
16 cicatricial pemphigoid 11.6
17 ocular cicatricial pemphigoid 11.6
18 gastritis 11.4
19 mallory-weiss syndrome 11.2
20 squamous cell carcinoma, head and neck 11.1
21 lymphoma, mucosa-associated lymphoid type 11.1
22 schimmelpenning-feuerstein-mims syndrome 11.1
23 allergic rhinitis 11.0
24 oral candidiasis 11.0
25 gastritis, familial giant hypertrophic 11.0
26 eosinophilic gastroenteritis 11.0
27 severe cutaneous adverse reaction 11.0
28 granular cell tumor 11.0
29 intestinal tuberculosis 11.0
30 cyclic neutropenia 11.0
31 secretory component deficiency 11.0
32 hemophilia a 11.0
33 exstrophy of bladder 11.0
34 esophageal varix 11.0
35 chronic mucocutaneous candidiasis 11.0
36 lassa fever 11.0
37 immunoglobulin a deficiency 1 10.9
38 telangiectasia, hereditary hemorrhagic, type 4 10.9
39 plasminogen deficiency, type i 10.8
40 factor x deficiency 10.8
41 bleeding disorder, platelet-type, 8 10.8
42 dyskeratosis congenita, autosomal dominant 2 10.8
43 dyskeratosis congenita, autosomal dominant 3 10.8
44 dyskeratosis congenita, autosomal recessive 5 10.8
45 autoinflammatory syndrome, familial, behcet-like 10.8
46 mastoiditis 10.8
47 recessive dystrophic epidermolysis bullosa-generalized other 10.8
48 darier-white disease 10.7
49 iga nephropathy 1 10.7
50 telangiectasia, hereditary hemorrhagic, type 1 10.7

Graphical network of the top 20 diseases related to Mucositis:



Diseases related to Mucositis

Symptoms & Phenotypes for Mucositis

UMLS symptoms related to Mucositis:


oral manifestations, signs and symptoms, digestive, catarrh

MGI Mouse Phenotypes related to Mucositis:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 growth/size/body region MP:0005378 10.25 EGF IL2 ABCB1 FGF7 CSF2 GLP2R
2 behavior/neurological MP:0005386 10.22 IL2 ABCB1 FGF7 CSF2 GLP2R HTR3A
3 homeostasis/metabolism MP:0005376 10.18 IL2 ABCB1 FGF7 CSF2 GLP2R HTR3A
4 endocrine/exocrine gland MP:0005379 10.11 EGF IL2 ABCB1 CSF2 GLP2R HTR3A
5 immune system MP:0005387 10.07 HTR3A EGF ABCB1 FGF7 CSF2 CSF3
6 integument MP:0010771 9.97 EGF FGF20 FGF7 CSF2 HTR3A CSF3
7 nervous system MP:0003631 9.96 HTR3A FGF20 ABCB1 FGF7 CSF2 MTOR
8 renal/urinary system MP:0005367 9.7 HTR3A FGF7 CSF2 CSF3 RSPO1 VEGFA
9 reproductive system MP:0005389 9.65 DPYD EGF IL2 ABCB1 FGF7 CSF2
10 skeleton MP:0005390 9.23 DPYD FGF7 CSF2 MTOR RSPO1 TGFB3

Drugs & Therapeutics for Mucositis

Drugs for Mucositis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 546)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 22916-47-8 4189
2
Nystatin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 1400-61-9 11953884
3
Cetuximab Approved Phase 4,Phase 3,Phase 1,Phase 2 205923-56-4 56842117 2333
4
Fluorouracil Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 51-21-8 3385
5
Cilastatin Approved, Investigational Phase 4 82009-34-5 5280454 6435415
6
Imipenem Approved Phase 4 74431-23-5, 64221-86-9 104838
7
Meropenem Approved, Investigational Phase 4 119478-56-7 64778 441130
8
Melphalan Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 148-82-3 4053 460612
9
Morphine Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 57-27-2 5288826
10
Docetaxel Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 114977-28-5 148124
11
Posaconazole Approved, Investigational, Vet_approved Phase 4,Phase 3 171228-49-2 147912
12
Zinc Approved, Investigational Phase 4,Phase 2,Phase 3 7440-66-6 23994
13
Metronidazole Approved Phase 4 443-48-1 4173
14
Chlorhexidine Approved, Vet_approved Phase 4,Phase 2,Not Applicable 55-56-1 9552079 2713
15
Ethanol Approved Phase 4,Phase 1 64-17-5 702
16
Hexetidine Approved, Investigational Phase 4 141-94-6
17
Budesonide Approved Phase 4,Phase 2 51333-22-3 63006 5281004
18
Lenograstim Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 135968-09-1
19
Micafungin Approved, Investigational Phase 4 235114-32-6 3081921 477468
20
Capecitabine Approved, Investigational Phase 4,Phase 2 154361-50-9 60953
21
Heparin Approved, Investigational Phase 4,Phase 1 9005-49-6 772 46507594
22
Irinotecan Approved, Investigational Phase 4,Phase 3,Phase 2 97682-44-5, 100286-90-6 60838
23
Amifostine Approved, Investigational Phase 4,Phase 2 20537-88-6 2141
24
Norethindrone Approved Phase 4 68-22-4 6230
25
Citric Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 77-92-9 311
26
Vitamin C Approved, Nutraceutical Phase 4,Phase 3,Phase 2 50-81-7 5785 54670067
27
Camptothecin Experimental Phase 4,Phase 3,Phase 2 7689-03-4
28 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
29 Antifungal Agents Phase 4,Phase 2,Phase 3,Phase 1
30 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
31 Calcium, Dietary Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
32 Ionophores Phase 4,Phase 3,Phase 2
33 Pharmaceutical Solutions Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable
34 Alkylating Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
35 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
36 Antimetabolites Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
37 Antimetabolites, Antineoplastic Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
38 Immunosuppressive Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
39 Mitomycins Phase 4
40 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
41 Antitubercular Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
42 HIV Protease Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
43
protease inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
44 Thienamycins Phase 4
45 Micronutrients Phase 4,Phase 2,Phase 3,Phase 1
46 Trace Elements Phase 4,Phase 2,Phase 3,Phase 1
47 Antiparasitic Agents Phase 4,Phase 3,Phase 2
48 Antiprotozoal Agents Phase 4,Phase 3,Phase 2
49 Analgesics Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
50 Analgesics, Opioid Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

Interventional clinical trials:

(show top 50) (show all 591)
# Name Status NCT ID Phase Drugs
1 Effectiveness of Low Energy Laser Treatment in Oral Mucositis Induced by Chemotherapy and Radiotherapy in Head and Neck Cancer Unknown status NCT01876407 Phase 4
2 Oral Hygiene Regimen in Patients on HCT Unknown status NCT02662374 Phase 4 .02% Chlorohexidine Gluconate;3% Sodium Bicarbonate;Nystatin 10000U/ml;Supersaturated Calcium Phosphate
3 Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and Neck Unknown status NCT02015650 Phase 4 Cetuximab;Mitomycin-C/ 5-Fluorouracil
4 Role of Healthy Bacteria in Ulcerative Colitis Unknown status NCT01479660 Phase 4 Probiotic
5 Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUO Unknown status NCT02149329 Phase 4 Discontinuation of imipenem-cilastatin or meropenem
6 A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients Completed NCT01283906 Phase 4
7 Oral Zinc Therapy for the Prevention of Mucositis Completed NCT00449592 Phase 4 Zinc;Placebo
8 PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation Completed NCT00352703 Phase 4 Kepivance (Palifermin)
9 Non Surgical Treatment of Periimplantitis Completed NCT02023853 Phase 4 metronidazole gel
10 Topical Morphine for Stomatitis-related Pain Induced by Chemotherapy Completed NCT00357942 Phase 4 morphine solution for injection;Placebo;morphine mouthwash;Placebo
11 INEC Study: Immuno-modulating Enteral Nutrition in Cancer Completed NCT00333099 Phase 4
12 Tolerability, Efficacy and Mucosal Inflammation Associated With Orally Administered Colon Cleansing for Colonoscopy Completed NCT00750763 Phase 4 Colonlytely;Picolax/Picoprep;Fleet
13 Hexetidine and Chlorobutanol for Lesions Due to Prostheses Completed NCT01115049 Phase 4 chlorobutanol, hexetidine;Chlorhexidine
14 Mouth Care Regimes During Radiotherapy Completed NCT00138827 Phase 4 Biotene (mouth care)
15 The Optimal Head Position for Distributing Topical Nasal Medication Using the Mucosal Atomization Device Completed NCT02079792 Phase 4
16 Glutamine Popsicles in Bone Marrow Transplant (BMT)/Hematopoietic Stem Cell Transplant (HSCT) Patients Completed NCT00204958 Phase 4 nutritional supplement;glutamine popsicle
17 A Clinical Trial of Patients With Solid Tumours Receiving Granulocyte Colony Stimulating Factor as Primary Prophylaxis for Chemotherapy-induced Neutropenia, in a Docetaxel Based Regimen Completed NCT01107756 Phase 4 LENOGRASTIM (GRANOGYTE 34)
18 Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome Completed NCT01200355 Phase 4 micafungin;posaconazole
19 Allergic Rhinitis Changes the Sinus Microbiome Completed NCT01852513 Phase 4 QNASL;Placebo nasal spray
20 The Effect of Prasugrel on Bronchial Hyperreactivity and on Markers of Inflammation in Patients With Chronic Asthma Completed NCT01305369 Phase 4 Prasugrel
21 Pharmacology-driven Dosing of Fluoropyrimidines in Cancer Patients Completed NCT01641458 Phase 4
22 Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI Tumours Completed NCT00220168 Phase 4 Irinotecan, Capecitabine
23 Subcutaneous Amifostine Safety Study Completed NCT00158041 Phase 4 Amifostine administered subcutaneously
24 Gelclair at Conditioning or After Oral Mucositis Diagnosed vs. Magic Mouth Wash in Stem Cell Transplant Recipients Recruiting NCT03490396 Phase 4
25 Effect of Lactobacillus Brevis CD2 in Prevention of Radio-chemotherapy Induced Oral Mucositis in Head and Neck Cancer Recruiting NCT01707641 Phase 4
26 Pharmacokinetics of Posaconazole (Noxafil®) as Prophylaxis for Invasive Fungal Infections Recruiting NCT02805946 Phase 4 posaconazole
27 A Research About Nutrition Impact for Local Advanced Nasopharyngeal Carcinoma Patients Recruiting NCT02948699 Phase 4
28 The Effect of Norethisterone Enanthate on Recurrent Bacterial Vaginosis Recruiting NCT02905890 Phase 4 Norethisterone enantate
29 PPI and Microbiome in Healthy Volunteers Recruiting NCT03545243 Phase 4 Pantoprazole 40mg
30 Effect of Probiotic Lactobacillus Reuteri in the Treatment of Mucositis and Periimplantitis Active, not recruiting NCT03047291 Phase 4 Probiotic
31 Impact of Oral Hygiene Gels on Peri-implant Mucositis Active, not recruiting NCT03243591 Phase 4
32 Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine Suspended NCT01288625 Phase 4 Amifostine
33 Low-energy Laser Therapy for Prevention of Oral Mucositis in Children Unknown status NCT01007617 Phase 2, Phase 3
34 Laser Therapy Prevents Mucositis Oral in Chemotherapy for Bone Marrow Transplantation? Unknown status NCT02020928 Phase 3
35 Palifermin for Patients Receiving Hematopoietic Stem Cell Transplantation Unknown status NCT02313792 Phase 3 Palifermin
36 Lactobacillus Brevis CD2 Preventing Oral Mucositis Unknown status NCT02085694 Phase 2, Phase 3 Lactobacillus brevis CD2
37 Evaluation of Oral Morphine Gel in Oral Mucositis Induced by Chemotherapy in Children and Young Adults Unknown status NCT02173756 Phase 3 morphine gel;placebo gel
38 Oral Glutamine and Mucositis of Head and Neck Cancer Patients Undergoing Radiation Unknown status NCT02282839 Phase 3
39 The Clinical Study for Evaluation of Efficacy and Safety of EGF on Oral Mucositis in Radiation Therapy Patients Unknown status NCT01099891 Phase 3 rhEGF;Placebo
40 Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer Unknown status NCT00022373 Phase 3 iseganan HCl oral solution
41 The Effect of Folinic Acid Rescue Following MTX GVHD Prophylaxis on Regimen Related Toxicity and Transplantation Outcome Unknown status NCT02506231 Phase 2, Phase 3 Folinic acid;Placebo
42 Standard Chemotherapy With or Without Nelarabine or Rituximab in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Unknown status NCT01085617 Phase 3 cyclophosphamide;cytarabine;daunorubicin hydrochloride;etoposide;fludarabine phosphate;imatinib mesylate;melphalan;mercaptopurine;methotrexate;nelarabine;pegaspargase;vincristine sulfate
43 Omalizumab in Non-atopic Asthma Unknown status NCT01113437 Phase 2, Phase 3 Omalizumab;Placebo
44 COX-2 Inhibitor With Concurrent Chemoradiation in Locally Advanced Head & Neck Carcinoma Unknown status NCT00603759 Phase 3 celecoxib;placebo
45 Comparison of Cy-Atg vs Flu-Atg for the Conditioning Therapy in Allo-HCT for Adult Aplastic Anemia Unknown status NCT01145976 Phase 3 Cy-ATG;Flu-ATG
46 Endostatin in Combination With Chemotherapy for Metastatic Nasopharyngeal Carcinoma Unknown status NCT01915134 Phase 3 Recombinant Human Endostatin plus gemcitabine and cisplatin;Gemcitabine and cisplatin
47 Efficacy Study of Neoadjuvant Chemotherapy With Chemoradiation Therapy for Nasopharyngeal Carcinoma Unknown status NCT01536223 Phase 3 PF (cisplatin and 5-fluorouracil) group;TPF (docetaxel plus cisplatin and 5-fluorouracil) group
48 Efficacy of Prophylactic Treatment With Antibiotics During Concomitant Chemoradiotherapy in Patients With Head and Neck Cancer to Prevent Aspiration Pneumonia Unknown status NCT01598402 Phase 2, Phase 3 amoxicillin/clavulanic acid suspension
49 Combination of Cisplatin Plus Gemcitabine Induction Chemotherapy and Intensity-modulated radiotherapyIntensity-modulated Radiotherapy With or Without Concurrent Cisplatin for NPC Unknown status NCT01854203 Phase 2, Phase 3 Inductive chemotherapy + concurrent cisplatin and IMRT;Inductive chemotherapy + IMRT
50 Magic Mouthwash Plus Sucralfate Versus Benzydamine Hydrochloride for the Treatment of Radiation-induced Mucositis Completed NCT00814359 Phase 3 Combination of Magic Mouthwash Plus Sucralfate;0.15% Benzydamine HCl

Search NIH Clinical Center for Mucositis

Cochrane evidence based reviews: mucositis

Genetic Tests for Mucositis

Anatomical Context for Mucositis

MalaCards organs/tissues related to Mucositis:

41
Colon, T Cells, Bone, Bone Marrow, Myeloid, Lung, Skin

Publications for Mucositis

Articles related to Mucositis:

(show top 50) (show all 2889)
# Title Authors Year
1
Mucosal melanoma: clinical and genetic profile. ( 29797459 )
2018
2
Fulminant presentation of oral mucosal leishmaniasis as severe stomatitis and periodontitis. ( 29380732 )
2018
3
Restoration of mucosal integrity and epithelial transport function by concomitant anti-TNFI+ treatment in chronic DSS-induced colitis. ( 29967942 )
2018
4
An unusual presentation of primary pulmonary extranodal marginal zone lymphoma of mucosal associated lymphoid tissue: An autopsy case report. ( 29452080 )
2018
5
Letter: mucosal response in discriminating intestinal tuberculosis from Crohn's disease-when to look for it? ( 29446132 )
2018
6
Patient with mediastinitis caused by delayed mucosal damage after peroral endoscopic myotomy. ( 29656451 )
2018
7
Peri-implant health, peri-implant mucositis, and peri-implantitis: Case definitions and diagnostic considerations. ( 29926496 )
2018
8
Conjunctivitis, mucosal erosions, and moist cutaneous plaques. ( 29349113 )
2018
9
Modified treatment of distichiasis with direct tarsal strip excision without mucosal graft. ( 29313390 )
2018
10
Randomized clinical trial of a mucoadhesive formulation containing curcuminoids (Zingiberaceae) and Bidens pilosa Linn (Asteraceae) extract (FITOPROT) for prevention and treatment of oral mucositis - phase I study. ( 29906455 )
2018
11
Mucositis with anti-EGFR monoclonal antibody in cancer patients: a meta-analysis of randomized controlled trials. ( 29893861 )
2018
12
Clinical patterns and management of primary mucosal melanoma: a single centre experience. ( 29388353 )
2018
13
Updates in the management of sinonasal mucosal melanoma. ( 29095708 )
2018
14
Efficacy of Plantago major, chlorhexidine 0.12% and sodium bicarbonate 5% solution in the treatment of oral mucositis in cancer patients with solid tumour: A feasibility randomised triple-blind phase III clinical trial. ( 29353631 )
2018
15
Mucosal Melanoma: a Literature Review. ( 29569184 )
2018
16
Anorectal mucosal melanoma. ( 29492238 )
2018
17
Mucosal-Associated Invariant T Cells Augment Immunopathology and Gastritis in Chronic<i>Helicobacter pylori</i>Infection. ( 29378910 )
2018
18
VT-1598 inhibits the in vitro growth of mucosal Candida strains and protects against fluconazole-susceptible and -resistant oral candidiasis in IL-17 signalling-deficient mice. ( 29788070 )
2018
19
Role of Radiotherapy in Mucosal Kaposi Sarcoma. ( 29383006 )
2018
20
Extranodal Rosai-Dorfman Disease With Mucosal Involvement of the Stomach in a Background of Autoimmune Atrophic Gastritis. ( 29720012 )
2018
21
The B-ADENOMA Study: Bowelscope - Accuracy of Detection using Endocuff Optimisation of Mucosal Abnormalities: Study Protocol for randomised controlled trial. ( 29978008 )
2018
22
Preserving Basement Membranes during Detachment of Cultivated Oral Mucosal Epithelial Cell Sheets for the Treatment of Total Bilateral Limbal Stem Cell Deficiency. ( 29637812 )
2018
23
Intestinal Mucosal-Associated Lymphoid Tissue Lymphoma Mimicked Cryptogenic Multifocal Ulcerous Stenosing Enteritis. ( 29692391 )
2018
24
Treatment of symptomatic oral mucositis with sodium hyaluronate and synthetic amino acid precursors of collagen in patients undergoing haematopoietic stem cell transplantation. ( 29921408 )
2018
25
Approaches to regional lymph node metastasis in patients with head and neck mucosal melanoma. ( 29044491 )
2018
26
Adenoma recurrence after endoscopic mucosal resection: propensity score analysis of old and new colonoscopes and Sydney recurrence tool implementation. ( 29423433 )
2018
27
Randomized, Double-Blind, Placebo-Controlled Trial of Shuanghua Baihe Tablets to Prevent Oral Mucositis in Patients With Nasopharyngeal Cancer Undergoing Chemoradiation Therapy. ( 29353657 )
2018
28
Prolonged Recurrent Abdominal Pain is Associated With Ongoing Underlying Mucosal Inflammation in Patients who had an Episode of Acute Complicated Diverticulitis. ( 29356787 )
2018
29
Patient and oncologist perceptions regarding symptoms and impact on quality-of-life of oral mucositis in cancer treatment: results from the Awareness Drives Oral Mucositis PercepTion (ADOPT) study. ( 29387994 )
2018
30
Unusual yellow scaly colonic mucosal appearance: Tangier disease. ( 29352969 )
2018
31
Dysplasia Should Not Be Ignored in Lichenoid Mucositis. ( 29328891 )
2018
32
Primary sinonasal mucosal melanoma simulated as cystic lesions: a case report. ( 29535967 )
2018
33
Management of long segment anterior urethral stricture (a8Y 8cm) using buccal mucosal (BM) graft and penile skin (PS) flap: outcome and predictors of failure. ( 29211404 )
2018
34
Mycoplasma pneumoniae-associated mucositis with severe blistering stomatitis and pneumonia successfully treated with azithromycin and infusion therapy. ( 29952018 )
2018
35
C5a receptor targeting of partial non-structural protein 3 of dengue virus promotes antigen-specific IFN-I^-producing T-cell responses in a mucosal dengue vaccine model. ( 29397905 )
2018
36
Clinical Characteristics of Children and Adolescents Undergoing Hematopoietic Cell Transplantation Who Develop Oral Mucositis. ( 29947353 )
2018
37
Reply to mucosal melanoma: clinical and genetic profile. ( 29799644 )
2018
38
Mucosal fixed drug eruption due to mefenamic acid: Report of a case and a review. ( 29525693 )
2018
39
Locally advanced oral squamous cell carcinoma patients treated with photobiomodulation for prevention of oral mucositis: retrospective outcomes and safety analyses. ( 29423682 )
2018
40
Distinct Gene Expression Patterns between Nasal Mucosal Cells and Blood Collected from Allergic Rhinitis Sufferers. ( 29920501 )
2018
41
Esophageal Mucosal Calcinosis: A Rare Site of Gastrointestinal Mucosal Calcinosis. ( 29622763 )
2018
42
Intestinal isosporiasis in patients with acquired immunodeficiency syndrome (AIDS). Pathologic diagnosis in small intestinal mucosal biopsies. ( 29566942 )
2018
43
Peri-implant health, peri-implant mucositis, and peri-implantitis: Case definitions and diagnostic considerations. ( 29926953 )
2018
44
Contemporary Treatment Approaches to Sinonasal Mucosal Melanoma. ( 29492677 )
2018
45
Analysis of TSC1 mutation spectrum in mucosal melanoma. ( 29185092 )
2018
46
Re: Repair of pan-urethral stricture: Proximal ventral and distal dorsal onlay technique of buccal mucosal graft urethroplasty. By Subbarao Chodisetti, Yogesh Boddepalli, Malakondareddy Kota. ( 29892485 )
2018
47
ELANE gene mutation-induced cyclic neutropenia manifesting as recurrent fever with oral mucosal ulcer: A case report. ( 29517659 )
2018
48
Multifactorial Analysis of Prognostic Factors and Survival Rates Among 706 Mucosal Melanoma Patients. ( 29748886 )
2018
49
Letter: mucosal response in discriminating intestinal tuberculosis from Crohn's disease-when to look for it? Authors' reply. ( 29446137 )
2018
50
Onset, progression and resolution of experimental peri-implant mucositis at different abutment surfaces: A randomized controlled two-centre study. ( 29331021 )
2018

Variations for Mucositis

Expression for Mucositis

Search GEO for disease gene expression data for Mucositis.

Pathways for Mucositis

Pathways related to Mucositis according to GeneCards Suite gene sharing:

(show all 32)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.74 CSF2 CSF3 EGF FGF20 FGF7 IL11
2
Show member pathways
13.39 EGF FGF20 FGF7 IL11 IL2 MTOR
3
Show member pathways
13.22 CSF2 CSF3 EGF FGF20 FGF7 IL11
4
Show member pathways
13.2 CSF2 CSF3 EGF FGF20 FGF7 IL11
5
Show member pathways
13.18 EGF FGF20 FGF7 IL2 TGFB3 VEGFA
6
Show member pathways
13.14 CSF2 CSF3 EGF FGF20 FGF7 IL11
7
Show member pathways
12.96 EGF FGF20 FGF7 IL2 MTOR TGFB3
8
Show member pathways
12.94 EGF FGF20 FGF7 IL2 MTOR TGFB3
9
Show member pathways
12.8 CSF3 EGF FGF20 FGF7 IL2 MTOR
10
Show member pathways
12.77 CSF2 EGF MTOR TGFB3 VEGFA
11
Show member pathways
12.68 EGF FGF20 FGF7 MTOR VEGFA
12 12.68 EGF FGF20 FGF7 TGFB3 VEGFA
13
Show member pathways
12.64 ABCB1 EGF FGF20 FGF7 MTOR TGFB3
14
Show member pathways
12.58 EGF FGF20 FGF7 IL2 TGFB3
15 12.52 EGF FGF20 FGF7 IL2 MTOR TGFB3
16
Show member pathways
12.47 CSF2 MTOR TGFB3 VEGFA
17
Show member pathways
12.39 CSF2 CSF3 EGF IL11 IL2 MTOR
18
Show member pathways
12.38 EGF MTOR TGFB3 VEGFA
19
Show member pathways
12.3 EGF FGF20 FGF7 VEGFA
20 11.96 EGF FGF7 IL11 VEGFA
21 11.89 CSF2 CSF3 IL11 IL2
22 11.82 EGF MTOR VEGFA
23 11.8 CSF2 CSF3 IL11
24 11.71 CSF2 IL11 TGFB3 VEGFA
25 11.6 EGF IL2 MTOR
26
Show member pathways
11.57 CSF2 IL2 VEGFA
27 11.47 CSF2 CSF3 EGF FGF7
28 11.36 EGF FGF7 VEGFA
29
Show member pathways
11.18 EGF FGF20 FGF7 IL11 IL2 MTOR
30 11.14 EGF IL11 TGFB3 VEGFA
31 10.82 ABCB1 MTOR
32 10.73 CSF2 CSF3 IL11 IL2

GO Terms for Mucositis

Cellular components related to Mucositis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.32 CSF2 CSF3 EGF FGF20 FGF7 IL11
2 platelet alpha granule lumen GO:0031093 9.13 EGF TGFB3 VEGFA

Biological processes related to Mucositis according to GeneCards Suite gene sharing:

(show all 27)
# Name GO ID Score Top Affiliating Genes
1 response to drug GO:0042493 9.92 ABCB1 MTHFR TYMS XRCC1
2 regulation of molecular function GO:0065009 9.9 CSF2 FGF20 FGF7 IL2
3 platelet degranulation GO:0002576 9.81 EGF TGFB3 VEGFA
4 peptidyl-tyrosine phosphorylation GO:0018108 9.81 CSF2 EGF FGF20 FGF7
5 response to hypoxia GO:0001666 9.8 MTHFR TGFB3 VEGFA XRCC1
6 cytokine-mediated signaling pathway GO:0019221 9.8 CSF2 CSF3 IL11 IL2 VEGFA
7 phosphatidylinositol phosphorylation GO:0046854 9.78 EGF FGF20 FGF7
8 positive regulation of protein phosphorylation GO:0001934 9.78 IL2 MTOR RSPO1 VEGFA
9 positive regulation of peptidyl-serine phosphorylation GO:0033138 9.76 CSF3 IL11 VEGFA
10 regulation of signaling receptor activity GO:0010469 9.76 CSF2 CSF3 FGF20 FGF7 IL11 IL2
11 MAPK cascade GO:0000165 9.72 CSF2 EGF FGF20 FGF7 IL2
12 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.71 CSF2 IL2 VEGFA
13 response to ethanol GO:0045471 9.67 CSF3 HTR3A IL2 TYMS
14 positive regulation of protein kinase B signaling GO:0051897 9.65 CSF3 EGF FGF20 FGF7 MTOR
15 macrophage differentiation GO:0030225 9.63 CSF3 VEGFA
16 positive regulation of cell division GO:0051781 9.63 FGF7 TGFB3 VEGFA
17 mammary gland alveolus development GO:0060749 9.62 EGF VEGFA
18 monocyte differentiation GO:0030224 9.61 CSF2 VEGFA
19 growth GO:0040007 9.59 MTOR VEGFA
20 tetrahydrofolate interconversion GO:0035999 9.58 MTHFR TYMS
21 tetrahydrofolate metabolic process GO:0046653 9.57 MTHFR TYMS
22 response to folic acid GO:0051593 9.56 MTHFR TYMS
23 positive regulation of keratinocyte migration GO:0051549 9.55 FGF7 MTOR
24 voluntary musculoskeletal movement GO:0050882 9.52 MTOR XRCC1
25 neutrophil differentiation GO:0030223 9.43 CSF2 CSF3
26 positive regulation of peptidyl-tyrosine phosphorylation GO:0050731 9.43 CSF3 EGF FGF7 IL11 MTOR VEGFA
27 positive regulation of cell proliferation GO:0008284 9.32 CSF2 CSF3 EGF FGF20 FGF7 GLP2R

Molecular functions related to Mucositis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 protein tyrosine kinase activity GO:0004713 9.56 CSF2 EGF FGF20 FGF7
2 Ras guanyl-nucleotide exchange factor activity GO:0005088 9.55 CSF2 EGF FGF20 FGF7 IL2
3 phosphatidylinositol-4,5-bisphosphate 3-kinase activity GO:0046934 9.5 EGF FGF20 FGF7
4 cytokine activity GO:0005125 9.43 CSF2 CSF3 IL11 IL2 TGFB3 VEGFA
5 growth factor activity GO:0008083 9.28 CSF2 CSF3 EGF FGF20 FGF7 IL11

Sources for Mucositis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....